MEDICINE

Robots could assist doctors and nurses with monitoring patients, boosting efficiency.

The top pre-market NASDAQ stock market gainers are: Orexigen Therapeutics, VIVUS, Microvision, Aixtron, Dynamex, ASM International, Zix, Ryanair Holdings, Geron, and Oracle.

The World Health Organization has endorsed a new, rapid tuberculosis (TB) test that can diagnose the killer disease within two hours.

The top after-market NASDAQ stock market gainers are: Orexigen Therapeutics, Arena Pharmaceuticals, Mitcham Industries, VIVUS, Casella Waste Systems, Scientific Games, Discovery Communications, Digirad, Amylin Pharmaceuticals, DIRECTV, and Lamar Advertising.

The top pre-market NASDAQ stock market gainers are: Cytori Therapeutics, Spectrum Pharmaceuticals, Zix, Powerwave Technologies, optionsXpress Holdings, Interactive Brokers Group, Qiao Xing Universal Resources, Seagate Technology, and Fifth Third Bancorp.

The top after-market NASDAQ stock market losers are: Abiomed, Fuel Systems Solutions, Geron, Wintrust Financial, Avago Technologies, James River Coal, Micrel, Celgene, United Therapeutics, and Novatel Wireless.

The top pre-market NASDAQ stock market gainers are: Verigy, Radware, Rambus, Nova Measuring Instruments, ASM International, VIVUS, optionsXpress Holdings, Ariad Pharmaceuticals, Geron, and DryShips.

Researchers from Australia are using data mining techniques to treat and prevent depression.

From hotel-style room service to massage therapy to magnificent views, hospitals are increasingly advertise their luxury services in a bid to gain market share, particularly those in competitive urban markets.

A U.K. biotechnology company called Oxitec has tested genetically engineering mosquitoes to pass on a suicide gene that kills them before they mature, to control the spread of dengue, a sometimes fatal disease.

Yearly global emissions of anaesthetic agents can be compared with that of carbon dioxide emissions from one million cars or one coal-fired power plant, says a study.

Merck & Co. Inc. said it agreed to acquire privately-held diabetes treatment developer SmartCells Inc. in a deal that could exceed $500 million.

Drug regimens are showing promising results as methods of preventing HIV infection.

Researchers in London have found a new way to treat hamstring injuries and treatment is none other than the patient's own blood.

Excessive intake of alcohol takes toll on the health of New Yorkers, besides causing death of 1,500 adults annually.

Michael Douglas on Thanksgiving holiday

The Transportation Security Administration is referencing a Johns Hopkins study on its web site, saying that the full-body x-ray scanners are safe to use. But the university's scientists are unhappy with the way that study is being used.

Government officials are mounting a campaign ahead of the busy holidays to explain why some holiday travelers may be subjected to airport security pat-downs requiring officers to touch their breasts and genitals.

Researchers in the United States have developed a new biosensor from plasmonic nanohole arrays to detect dangerous viruses like Ebola and Marburg. The tool could be used in developing nations, airports and other places where natural or man-made outbreaks could erupt.

Using particles of gold, ultrasound and an infrared laser, scientists can now see into the body in m,ore detail than ever before.

Pfizer Inc. and Bristol-Myers Squibb Co. said they have halted a late-stage study of their experimental blood-thinner apixaban because of safety concerns.